Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare ...

Who is eligible for both Medicare and Medicaid in California? Beneficiaries with dual eligibility Wegovy has gained attention as a powerful weight loss medication, especially for those struggling ...

Novo Nordisk is providing direct-to-patient delivery of Wegovy (semaglutide) through the NovoCare Pharmacy program.

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

Adults with obesity who have a prescription for Wegovy but do not have insurance coverage for the drug can now purchase the ...

Novo Nordisk said Wednesday it will sell Wegovy for $499 a month in cash to ... directly to patients who lack insurance or whose health plan doesn’t cover obesity medications.

Wegovy, a glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated in combination with a reduced calorie diet and increased physical activity to: Through the NovoCare Pharmacy program ...

Novo Nordisk spokesperson Jamie Bennett said the company plans to extend the $499 price to cash-paying customers at other pharmacies "in the near future." The list price for Wegovy remains at $ ...